1
|
Prunas C, Krane-Gartiser K, Nevoret C, Benard V, Benizri C, Brochard H, Faedda G, Geoffroy PA, Gross G, Katsahian S, Maruani J, Yeim S, Leboyer M, Bellivier F, Scott J, Etain B. Does childhood experience of attention-deficit hyperactivity disorder symptoms increase sleep/wake cycle disturbances as measured with actigraphy in adult patients with bipolar disorder? Chronobiol Int 2019; 36:1124-1130. [PMID: 31169034 DOI: 10.1080/07420528.2019.1619182] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Childhood attention-deficit hyperactivity disorder (ADHD) is a common precursor of adult bipolar disorders (BD). Furthermore, actigraphy studies demonstrate that each disorder may be associated with abnormalities in sleep and activity patterns. This study investigates whether the presence or absence of self-reported childhood experiences of ADHD symptoms is associated with different sleep and activity patterns in adults with BD. A sample of 115 euthymic adult patients with BD was assessed for childhood ADHD symptoms using the Wender Utah Rating Scale (WURS) and then completed 21 days of actigraphy monitoring. Actigraphic measures of sleep quantity and variability and daytime activity were compared between BD groups classified as ADHD+ (n = 24) or ADHD- (n = 91), defined according to established cutoff scores for the WURS; then we examined any associations between sleep-wake cycle parameters and ADHD dimensions (using the continuous score on the WURS). Neither approach revealed any statistically significant associations between actigraphy parameters and childhood ADHD categories or dimensions. We conclude that the sleep and activity patterns of adult patients with BD do not differ according to their self-reported history of ADHD symptoms. We discuss the implications of these findings and suggest how future studies might confirm or refute our findings.
Collapse
Affiliation(s)
- C Prunas
- a INSERM U1144, Optimisation Thérapeutique en Neuropsychopharmacologie , Paris , France.,b Department of Neurosciences and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico , University of Milan , Milan , Italy
| | - K Krane-Gartiser
- a INSERM U1144, Optimisation Thérapeutique en Neuropsychopharmacologie , Paris , France.,c Department of Mental Health, NTNU , Norwegian University of Science and Technology , Trondheim , Norway.,d Department of Psychiatry , St. Olav's University Hospital , Trondheim , Norway
| | - C Nevoret
- e INSERM, UMR_S 1138 , Université Paris Descartes, Sorbonne Universités, UPMC Université Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers , Paris , France.,f Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges-Pompidou , Unité d'Épidémiologie et de Recherche Clinique , Paris , France.,g INSERM, Centre d'Investigation Clinique 1418, module Épidémiologie Clinique , Paris , France
| | - V Benard
- a INSERM U1144, Optimisation Thérapeutique en Neuropsychopharmacologie , Paris , France
| | - C Benizri
- h INSERM U955, Equipe Psychiatrie Translationnelle , Créteil , France
| | - H Brochard
- i Pôle sectoriel, Centre Hospitalier Fondation Vallée , Gentilly , France
| | - G Faedda
- j Lucio Bini Mood Disorders Center , New York , NY , USA
| | - P A Geoffroy
- a INSERM U1144, Optimisation Thérapeutique en Neuropsychopharmacologie , Paris , France.,k Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, Assistance, Publique des Hôpitaux de Paris , Paris , France.,l Sorbonne Paris Cité , Université Paris Diderot , Paris , France
| | - G Gross
- a INSERM U1144, Optimisation Thérapeutique en Neuropsychopharmacologie , Paris , France
| | - S Katsahian
- e INSERM, UMR_S 1138 , Université Paris Descartes, Sorbonne Universités, UPMC Université Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers , Paris , France.,f Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges-Pompidou , Unité d'Épidémiologie et de Recherche Clinique , Paris , France.,g INSERM, Centre d'Investigation Clinique 1418, module Épidémiologie Clinique , Paris , France
| | - J Maruani
- k Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, Assistance, Publique des Hôpitaux de Paris , Paris , France
| | - S Yeim
- k Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, Assistance, Publique des Hôpitaux de Paris , Paris , France
| | - M Leboyer
- h INSERM U955, Equipe Psychiatrie Translationnelle , Créteil , France.,m Fondation FondaMental , Créteil , France.,n AP-HP, Hôpitaux Universitaires Henri Mondor, DHU Pepsy, Pôle de Psychiatrie et d'Addictologie , Créteil , France.,o Université Paris Est Créteil, Faculté de Médecine , Creteil , France
| | - F Bellivier
- a INSERM U1144, Optimisation Thérapeutique en Neuropsychopharmacologie , Paris , France.,k Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, Assistance, Publique des Hôpitaux de Paris , Paris , France.,l Sorbonne Paris Cité , Université Paris Diderot , Paris , France.,m Fondation FondaMental , Créteil , France
| | - J Scott
- c Department of Mental Health, NTNU , Norwegian University of Science and Technology , Trondheim , Norway.,l Sorbonne Paris Cité , Université Paris Diderot , Paris , France.,p Academic Psychiatry, Institute of Neuroscience , Newcastle University , UK.,q Centre for Affective Disorders , Institute of Psychiatry, Psychology and Neurosciences , London , UK
| | - B Etain
- a INSERM U1144, Optimisation Thérapeutique en Neuropsychopharmacologie , Paris , France.,k Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Widal, Assistance, Publique des Hôpitaux de Paris , Paris , France.,l Sorbonne Paris Cité , Université Paris Diderot , Paris , France.,m Fondation FondaMental , Créteil , France.,q Centre for Affective Disorders , Institute of Psychiatry, Psychology and Neurosciences , London , UK
| |
Collapse
|
2
|
Krane-Gartiser K, Scott J, Nevoret C, Benard V, Benizri C, Brochard H, Geoffroy PA, Katsahian S, Maruani J, Yeim S, Leboyer M, Bellivier F, Etain B. Which actigraphic variables optimally characterize the sleep-wake cycle of individuals with bipolar disorders? Acta Psychiatr Scand 2019; 139:269-279. [PMID: 30689212 DOI: 10.1111/acps.13003] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/04/2019] [Indexed: 01/07/2023]
Abstract
OBJECTIVE To examine which combination of objectively measured actigraphy parameters best characterizes the sleep-wake cycle of euthymic individuals with bipolar disorder (BD) compared with healthy controls (HC). METHODS Sixty-one BD cases and 61 matched HC undertook 21 consecutive days of actigraphy. Groups were compared using discriminant function analyses (DFA) that explored dimensions derived from mean values of sleep parameters (Model 1); variability of sleep parameters (2); daytime activity (3); and combined sleep and activity parameters (4). Exploratory within-group analyses examined characteristics associated with misclassification. RESULTS After controlling for depressive symptoms, the combined model (4) correctly classified 75% cases, while the sleep models (1 and 2) correctly classified 87% controls. The area under the curve favored the combined model (0.86). Age was significantly associated with misclassification among HC, while a diagnosis of BD-II was associated with an increased risk of misclassifications of cases. CONCLUSION Including sleep variability and activity parameters alongside measures of sleep quantity improves the characterization of cases of euthymic BD and helps distinguish them from HC. If replicated, the findings indicate that traditional approaches to actigraphy (examining mean values for the standard set of sleep parameters) may represent a suboptimal approach to understanding sleep-wake cycles in BD.
Collapse
Affiliation(s)
- K Krane-Gartiser
- Department of Mental Health, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.,Department of Psychiatry, St. Olav's University Hospital, Trondheim, Norway.,INSERM U1144, Paris, France
| | - J Scott
- Department of Mental Health, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.,Academic Psychiatry, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.,Sorbonne Paris Cité, Université Paris Diderot, Paris, France.,Centre for Affective Disorders, Institute of Psychiatry, London, UK
| | - C Nevoret
- INSERM, UMR_S 1138, Université Paris Descartes, Sorbonne Universités, UPMC Université Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.,Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Unité d'Épidémiologie et de Recherche Clinique, Paris, France.,INSERM, Centre d'Investigation Clinique 1418, Module Épidémiologie Clinique, Paris, France
| | | | - C Benizri
- Equipe Psychiatrie Translationnelle, INSERM U955, Créteil, France
| | - H Brochard
- Equipe Psychiatrie Translationnelle, INSERM U955, Créteil, France.,Pôle sectoriel, Centre Hospitalier Fondation Vallée, Gentilly, France
| | - P A Geoffroy
- INSERM U1144, Paris, France.,Sorbonne Paris Cité, Université Paris Diderot, Paris, France.,Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France.,Fondation FondaMental, Créteil, France
| | - S Katsahian
- INSERM, UMR_S 1138, Université Paris Descartes, Sorbonne Universités, UPMC Université Paris 06, UMR_S 1138, Centre de Recherche des Cordeliers, Paris, France.,Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Unité d'Épidémiologie et de Recherche Clinique, Paris, France.,INSERM, Centre d'Investigation Clinique 1418, Module Épidémiologie Clinique, Paris, France
| | - J Maruani
- Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France
| | - S Yeim
- Sorbonne Paris Cité, Université Paris Diderot, Paris, France.,Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France
| | - M Leboyer
- Equipe Psychiatrie Translationnelle, INSERM U955, Créteil, France.,Fondation FondaMental, Créteil, France.,AP-HP, Hôpitaux Universitaires Henri Mondor, DHU Pepsy, Pôle de Psychiatrie et d'Addictologie, Créteil, France.,Université Paris Est Créteil, Creteil, France
| | - F Bellivier
- INSERM U1144, Paris, France.,Sorbonne Paris Cité, Université Paris Diderot, Paris, France.,Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France.,Fondation FondaMental, Créteil, France
| | - B Etain
- INSERM U1144, Paris, France.,Sorbonne Paris Cité, Université Paris Diderot, Paris, France.,Centre for Affective Disorders, Institute of Psychiatry, London, UK.,Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France.,Fondation FondaMental, Créteil, France
| |
Collapse
|
3
|
Benard V, Etain B, Vaiva G, Boudebesse C, Yeim S, Benizri C, Brochard H, Bellivier F, Geoffroy PA. Sleep and circadian rhythms as possible trait markers of suicide attempt in bipolar disorders: An actigraphy study. J Affect Disord 2019; 244:1-8. [PMID: 30290235 DOI: 10.1016/j.jad.2018.09.054] [Citation(s) in RCA: 49] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2018] [Revised: 08/09/2018] [Accepted: 09/15/2018] [Indexed: 11/25/2022]
Abstract
BACKGROUND The poor prognostic of Bipolar disorders (BD) is closely linked to deaths by suicide. Sleep and circadian abnormalities are observed during all phases of BD and are also associated with suicide attempt (SA). In this context, this study sought to identify specific sleep and circadian rhythms markers associated with suicidal attempt in euthymic patients with BD. METHODS The sample (N = 236) comprised 3 groups: 147 patients with BD including 57 with a history of SA and 90 without (NoSA), and 89 healthy controls (HC). All participants were recorded during 21 days with actigraphy. RESULTS SA was associated with women gender (p = 0.03), familial history of SA (p = 0.03), mixed episodes (p = 0.001), and benzodiazepines (p = 0.019). SA, compared to noSA, had a morning phase preference (p = 0.04), and were more vigorous on the circadian type inventory (p = 0.04), and tended to suffer more from insomnia (45% versus 25% respectively, p = 0.10). SA was also associated with an earlier onset of daily activity assessed with actigraphy (M10 onset: p = 0.01). Backward stepwise linear regression indicated that a combination of four variables (Gender, vigour, insomnia, M10onset) significantly differentiated patients with SA from NoSA (p = 0.03). LIMITATIONS Cross-sectional design, and no examination of suicidal behaviors' subgroups such as first attempters or repeaters, or violent suicide attempt. CONCLUSIONS Woman gender, vigorous circadian type, insomnia and an earlier daily activity appeared independently associated with SA in BD. If these biomarkers are confirmed in prospective studies, they should be screened and used to prevent suicide, with the development of personal and targeted chronobiological treatments.
Collapse
Affiliation(s)
- V Benard
- Univ. Lille, CNRS, CHU Lille, UMR 9193 - SCALab - Sciences Cognitives et Sciences Affectives, Lille F-59000, France; Univ. Lille, CHRU Lille, Clinique de Psychiatrie, Unité CURE, Lille F-59000 France; Univ. Lille, Hôpital Fontan CHRU Lille F-59000, France
| | - B Etain
- AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris cedex 10 75475, France; Inserm, U1144, Paris F-75006, France; Université Paris Descartes, UMR-S 1144, Paris F-75006, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S 1144, Paris F-75013, France; Fondation FondaMental, Créteil 94000, France
| | - G Vaiva
- Univ. Lille, CNRS, CHU Lille, UMR 9193 - SCALab - Sciences Cognitives et Sciences Affectives, Lille F-59000, France; Univ. Lille, CHRU Lille, Clinique de Psychiatrie, Unité CURE, Lille F-59000 France; Univ. Lille, Hôpital Fontan CHRU Lille F-59000, France
| | - C Boudebesse
- AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris cedex 10 75475, France
| | - S Yeim
- AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris cedex 10 75475, France
| | - C Benizri
- AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris cedex 10 75475, France
| | - H Brochard
- AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris cedex 10 75475, France
| | - F Bellivier
- AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris cedex 10 75475, France; Inserm, U1144, Paris F-75006, France; Université Paris Descartes, UMR-S 1144, Paris F-75006, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S 1144, Paris F-75013, France; Fondation FondaMental, Créteil 94000, France
| | - P A Geoffroy
- AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Pôle de Psychiatrie et de Médecine Addictologique, Paris cedex 10 75475, France; Inserm, U1144, Paris F-75006, France; Université Paris Descartes, UMR-S 1144, Paris F-75006, France; Université Paris Diderot, Sorbonne Paris Cité, UMR-S 1144, Paris F-75013, France; Fondation FondaMental, Créteil 94000, France.
| |
Collapse
|
4
|
Brochard H, Godin O, Geoffroy PA, Yeim S, Boudebesse C, Benizri C, Benard V, Maruani J, Leboyer M, Bellivier F, Etain B. Metabolic syndrome and actigraphy measures of sleep and circadian rhythms in bipolar disorders during remission. Acta Psychiatr Scand 2018; 138:155-162. [PMID: 29845615 DOI: 10.1111/acps.12910] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/14/2018] [Indexed: 12/19/2022]
Abstract
OBJECTIVE This study explored the correlations between sleep and circadian rhythm measures and the metabolic syndrome (MetS) components in remitted patients with bipolar disorder (BD). METHOD Euthymic patients with BD (n = 67) were recorded by 3 weeks with actigraphy. We used nonparametric correlations to study the links between the MetS parameters, atherogenic index of plasma (AIP), sleep efficacy, sleep latency, fragmentation index, and phase and amplitude of rhythms. We performed multivariable analyses to take into account potential confounding factors such as sleep apnea risk, antipsychotics use, and smoker status. RESULTS We found correlations between lower sleep efficiency and higher triglyceride levels (P = 0.002), lower M10 onset (beginning of the 10 most active hours during the 24-h cycle) and higher systolic blood pressure (P = 0.03), higher fragmentation index and higher systolic blood pressure (P = 0.009), lower sleep efficiency, higher fragmentation index, and higher AIP (respectively P = 0.02 and P = 0.04). These correlations mostly remained significant when adjusting for confounders, with the exception of M10 onset and systolic blood pressure. CONCLUSION Sleep efficiency and fragmentation index might contribute to the cardiovascular risk of patients with BD independently of major confounding factors. Although these associations did not imply causality, proposing interventions on sleep quality and circadian rhythm regularity might contribute to reduce cardiovascular risk in patients with BD.
Collapse
Affiliation(s)
- H Brochard
- Pôle sectoriel, Centre Hospitalier Fondation Vallée, Gentilly, France
| | - O Godin
- Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), Sorbonne Universités, Université Pierre et Marie Curie, Paris, France.,INSERM, UMR_S 1136, Paris, France.,Fondation FondaMental, Créteil, France
| | - P A Geoffroy
- Fondation FondaMental, Créteil, France.,Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France.,Sorbonne Paris Cité, Université Paris Diderot, Paris, France.,INSERM U1144, Paris, France
| | - S Yeim
- Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France.,Sorbonne Paris Cité, Université Paris Diderot, Paris, France
| | - C Boudebesse
- AP-HP, Hôpitaux Universitaires Henri Mondor, DHU Pepsy, Pôle de Psychiatrie et d'Addictologie, Créteil, France
| | - C Benizri
- Equipe Psychiatrie Translationnelle, INSERM U955, Créteil, France
| | | | - J Maruani
- Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France
| | - M Leboyer
- Fondation FondaMental, Créteil, France.,AP-HP, Hôpitaux Universitaires Henri Mondor, DHU Pepsy, Pôle de Psychiatrie et d'Addictologie, Créteil, France.,Equipe Psychiatrie Translationnelle, INSERM U955, Créteil, France
| | - F Bellivier
- Fondation FondaMental, Créteil, France.,Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France.,Sorbonne Paris Cité, Université Paris Diderot, Paris, France.,INSERM U1144, Paris, France
| | - B Etain
- Fondation FondaMental, Créteil, France.,Département de Psychiatrie et de Médecine Addictologique, AP-HP, GH Saint-Louis - Lariboisière - F. Widal, Paris, France.,Sorbonne Paris Cité, Université Paris Diderot, Paris, France.,INSERM U1144, Paris, France
| |
Collapse
|